These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
105 related articles for article (PubMed ID: 11098079)
1. Co-expression of thymidine kinase and cathepsin D in 200 primary breast carcinomas. Greco S; Marsigliante S; Leo G; Storelli C Cancer Lett; 2000 Nov; 160(1):13-9. PubMed ID: 11098079 [TBL] [Abstract][Full Text] [Related]
2. Alterations of estrogen receptors, progesterone receptors and c-erbB2 oncogene protein expression in ductal carcinomas of the breast. Hussein MR; Abd-Elwahed SR; Abdulwahed AR Cell Biol Int; 2008 Jun; 32(6):698-707. PubMed ID: 18296077 [TBL] [Abstract][Full Text] [Related]
3. Dissociated overexpression of cathepsin D and estrogen receptor alpha in preinvasive mammary tumors. Roger P; Daures JP; Maudelonde T; Pignodel C; Gleizes M; Chapelle J; Marty-Double C; Baldet P; Mares P; Laffargue F; Rochefort H Hum Pathol; 2000 May; 31(5):593-600. PubMed ID: 10836299 [TBL] [Abstract][Full Text] [Related]
4. [Axillary lymph node involvement in hormone-independent breast carcinomas]. Ruibal A; Arias JI Med Clin (Barc); 2004 Jun; 123(2):50-2. PubMed ID: 15225483 [TBL] [Abstract][Full Text] [Related]
5. Estrogen-regulated cut-off values of pS2 and cathepsin D expression in breast carcinomas. Markićević M; Petrović A; Kanjer K; Nesković-Konstantinović Z; Nikolić-Vukosavujević D Adv Exp Med Biol; 2008; 617():341-8. PubMed ID: 18497057 [TBL] [Abstract][Full Text] [Related]
6. p53 protein expression and oestrogen and progesterone receptor status in invasive ductal breast carcinomas. Ioakim-Liossi A; Karakitsos P; Markopoulos C; Aroni K; Athanassiadou P; Delivelioti K; Athanassiades P; Vaiopoulos G Cytopathology; 2001 Jun; 12(3):197-202. PubMed ID: 11380561 [TBL] [Abstract][Full Text] [Related]
7. Correlation between genetic and biological aspects in primary non-metastatic breast cancers and corresponding synchronous axillary lymph node metastasis. D'Andrea MR; Limiti MR; Bari M; Zambenedetti P; Montagutti A; Ricci F; Pappagallo GL; Sartori D; Vinante O; Mingazzini PL Breast Cancer Res Treat; 2007 Mar; 101(3):279-84. PubMed ID: 16835704 [TBL] [Abstract][Full Text] [Related]
8. Relationship between cathepsin D and other pathological and biological parameters in 1752 patients with primary breast cancer. Gion M; Mione R; Dittadi R; Romanelli M; Pappagallo L; Capitanio G; Friede U; Barbazza R; Visonà A; Dante S Eur J Cancer; 1995; 31A(5):671-7. PubMed ID: 7640037 [TBL] [Abstract][Full Text] [Related]
9. Steroid receptor status and its clinicopathological correlation in post-menopausal breast cancer patients of Kumaon region of Uttarakhand. Shahi KS; Bhandari G; Singh A J Cancer Res Ther; 2011; 7(1):19-22. PubMed ID: 21546737 [TBL] [Abstract][Full Text] [Related]
10. Comparison of ER, PR and HER-2/neu (C-erb B 2) reactivity pattern with histologic grade, tumor size and lymph node status in breast cancer. Azizun-Nisa ; Bhurgri Y; Raza F; Kayani N Asian Pac J Cancer Prev; 2008; 9(4):553-6. PubMed ID: 19256737 [TBL] [Abstract][Full Text] [Related]
11. Evaluation of oestrogen and progesterone receptor status in HER-2 positive breast carcinomas and correlation with outcome. Francis G; Beadle G; Thomas S; Mengersen K; Stein S Pathology; 2006 Oct; 38(5):391-8. PubMed ID: 17008275 [TBL] [Abstract][Full Text] [Related]
12. Cyclin D1 expression in ductal carcinoma of the breast and its correlation with other prognostic parameters. Ravikumar G; Ananthamurthy A J Cancer Res Ther; 2014; 10(3):671-5. PubMed ID: 25313758 [TBL] [Abstract][Full Text] [Related]
13. Expression of sialyl lewis X, sialyl Lewis A, E-cadherin and cathepsin-D in human breast cancer: immunohistochemical analysis in mammary carcinoma in situ, invasive carcinomas and their lymph node metastasis. Jeschke U; Mylonas I; Shabani N; Kunert-Keil C; Schindlbeck C; Gerber B; Friese K Anticancer Res; 2005; 25(3A):1615-22. PubMed ID: 16033070 [TBL] [Abstract][Full Text] [Related]
14. Expression of cathepsin D and pS2 in imprint smears of breast carcinoma. Athanassiadou PP; Athanassiades PH; Davaris P; Petrakakou EI; Zerva CI; Kyrkou KA Cytopathology; 1998 Aug; 9(4):240-7. PubMed ID: 9710694 [TBL] [Abstract][Full Text] [Related]
15. Apocrine carcinoma as triple-negative breast cancer: novel definition of apocrine-type carcinoma as estrogen/progesterone receptor-negative and androgen receptor-positive invasive ductal carcinoma. Tsutsumi Y Jpn J Clin Oncol; 2012 May; 42(5):375-86. PubMed ID: 22450930 [TBL] [Abstract][Full Text] [Related]
16. Cathepsin D assay in primary breast cancer and lymph nodes: relationship with c-myc, c-erb-B-2 and int-2 oncogene amplification and node invasiveness. Brouillet JP; Theillet C; Maudelonde T; Defrenne A; Simony-Lafontaine J; Sertour J; Pujol H; Jeanteur P; Rochefort H Eur J Cancer; 1990 Apr; 26(4):437-41. PubMed ID: 2141510 [TBL] [Abstract][Full Text] [Related]
17. Expression of oestrogen and progesterone receptors, Ki-67, p53 and BCL-2 proteins, cathepsin D, urokinase plasminogen activator and urokinase plasminogen activator-receptors in carcinomas of the female breast in an African population. Mbonde MP; Amir H; Akslen LA; Kitinya JN East Afr Med J; 2001 Jul; 78(7):360-5. PubMed ID: 11957260 [TBL] [Abstract][Full Text] [Related]
18. Tumor growth fraction, expression of estrogen and progesterone receptors, p53, bcl-2 and cathepsin D activity in primary ductal invasive breast carcinoma and their axillary lymph node metastases. Kristek J; Dmitrović B; Kurbel S; Sakić K; Krajinović Z; Blazicević V; Has B; Marjanović K Coll Antropol; 2007 Dec; 31(4):1043-7. PubMed ID: 18217456 [TBL] [Abstract][Full Text] [Related]
19. Id-1 overexpression in invasive ductal carcinoma cells is significantly associated with intratumoral microvessel density in ER-negative/node-positive breast cancer. Jang KS; Han HX; Paik SS; Brown PH; Kong G Cancer Lett; 2006 Dec; 244(2):203-10. PubMed ID: 16469432 [TBL] [Abstract][Full Text] [Related]
20. Correlation between hormone receptor status and age, and its prognostic implications in breast cancer patients in Bahrain. AlZaman AS; Mughal SA; AlZaman YS; AlZaman ES Saudi Med J; 2016 Jan; 37(1):37-42. PubMed ID: 26739972 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]